Apeloa Pharmaceutical (000739.SZ) Obtains European CEP Certificate for Venlafaxine Hydrochloride API

Stock News

Nov 10

Apeloa Pharmaceutical Co., Ltd. (000739.SZ) announced that its wholly-owned subsidiary, Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd., recently received the Certificate of Suitability to the European Pharmacopoeia (CEP) for Venlafaxine Hydrochloride issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM).

Venlafaxine Hydrochloride is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat various types of depression (including depression with anxiety) and generalized anxiety disorder.

The approval of the CEP certificate for Venlafaxine Hydrochloride API demonstrates recognition of its quality by the regulated European market. This milestone confirms the product's eligibility to enter the EU and other markets that recognize CEP certification in API form, which will positively contribute to the company's further expansion into international markets.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1154494538"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1154494538\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1154494538?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-10 16:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154494538","market":"fut","top_or_hot":-1,"title":"Apeloa Pharmaceutical (000739.SZ) Obtains European CEP Certificate for Venlafaxine Hydrochloride API","media":"Stock News","content":"<p>Apeloa Pharmaceutical Co., Ltd. (000739.SZ) announced that its wholly-owned subsidiary, Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd., recently received the Certificate of Suitability to the European Pharmacopoeia (CEP) for Venlafaxine Hydrochloride issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM).</p>\n<p>Venlafaxine Hydrochloride is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat various types of depression (including depression with anxiety) and generalized anxiety disorder.</p>\n<p>The approval of the CEP certificate for Venlafaxine Hydrochloride API demonstrates recognition of its quality by the regulated European market. This milestone confirms the product's eligibility to enter the EU and other markets that recognize CEP certification in API form, which will positively contribute to the company's further expansion into international markets.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apeloa Pharmaceutical (000739.SZ) Obtains European CEP Certificate for Venlafaxine Hydrochloride API</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApeloa Pharmaceutical (000739.SZ) Obtains European CEP Certificate for Venlafaxine Hydrochloride API\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-10 16:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Apeloa Pharmaceutical Co., Ltd. (000739.SZ) announced that its wholly-owned subsidiary, Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd., recently received the Certificate of Suitability to the European Pharmacopoeia (CEP) for Venlafaxine Hydrochloride issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM).</p>\n<p>Venlafaxine Hydrochloride is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat various types of depression (including depression with anxiety) and generalized anxiety disorder.</p>\n<p>The approval of the CEP certificate for Venlafaxine Hydrochloride API demonstrates recognition of its quality by the regulated European market. This milestone confirms the product's eligibility to enter the EU and other markets that recognize CEP certification in API form, which will positively contribute to the company's further expansion into international markets.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0188","symbol_name":"融资融券","start_time":0,"source_url":"","article_id":"1154494538","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154494538","pubTimestamp":1762764381,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Apeloa Pharmaceutical Co., Ltd. (000739.SZ) announced that its wholly-owned subsidiary, Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd., recently received the Certificate of Suitability to the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK0188":"融资融券","CEP":"Cantor Equity Partners Inc","BK0060":"抗癌","000739":"普洛药业","BK0239":"医药制造"},"translate_title":"Apeloa Pharmaceutical(000739.SZ)获得盐酸文拉法辛原料药欧洲CEP证书","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CEP":1,"000739":1},"content_text":"Apeloa Pharmaceutical Co., Ltd. (000739.SZ) announced that its wholly-owned subsidiary, Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd., recently received the Certificate of Suitability to the European Pharmacopoeia (CEP) for Venlafaxine Hydrochloride issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM).\nVenlafaxine Hydrochloride is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat various types of depression (including depression with anxiety) and generalized anxiety disorder.\nThe approval of the CEP certificate for Venlafaxine Hydrochloride API demonstrates recognition of its quality by the regulated European market. This milestone confirms the product's eligibility to enter the EU and other markets that recognize CEP certification in API form, which will positively contribute to the company's further expansion into international markets.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}